Medtech contract manufacturing giant Integer Holdings announced that it has bought Quakertown, Pennsylvania–based Pulse Technologies. The size of the deal was roughly $140 million. It closed on Jan. 5 and utilized borrowings under Integer’s existing revolving credit facility. Pulse Technologies is a privately-held medtech supplier focusing on complex micromachining of medical device components for high-growth […]
ResMed CPAP masks recall is Class I
The FDA announced that ResMed’s voluntary recall of millions of CPAP mask magnets is now Class I, the agency’s most serious level. Last month, ResMed warned CPAP users about potential magnetic interference when magnets go near certain implants and medical devices in the body. People using CPAP masks with magnets only need to return […]
Nevro announces layoffs
Pain-treatment device company Nevro (NYSE:NVRO) announced that it is letting go of 63 employees, about 5% of its workforce, as part of a restructuring effort. “This restructuring supports our strategy and allows us to focus our investments to further position Nevro for long-term growth and profitability,” Nevro CEO Kevin Thornal said in a news release […]
AtriCure management expects Street-beating Q4 sales
AtriCure today announced preliminary fourth-quarter revenue results that beat the expectations of Wall Street analysts. The Mason, Ohio–based developer of surgical tools for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management expects to report Q4 2023 revenue of $106.5 million, up 21% year-over-year. The consensus on The Street was $102.43 million. […]
iRhythm releases strong Q4 prelims, strengthens balance sheet
iRhythm Technologies today released a solid preliminary earnings update that included projections of up to 20% revenue growth in 2024. The wearable cardiac monitors developer saw IRTC shares jump more than 7% in value to $112.91 apiece by the close of trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical […]
Medtronic wins FDA nod for ‘game-changing’ DBS device
Medtronic today announced FDA approval of its Percept RC deep brain stimulation system, the latest member of its Percept line of DBS devices. The medtech giant describes the Percept RC as the first DBS sensing-enable rechargeable device. In a presentation at the J.P. Morgan Healthcare Conference earlier today, CEO Geoff Martha called it a “game-changing” […]
Stanford Biodesign co-founder joins Sofinnova Partners
Sofinnova Partners — a prominent life sciences venture capital firm based in Paris, London, and Milan — has added Stanford Biodesign co-founder and director Dr. Joshua Makower as an advisory venture partner. It’s been 23 years since Makower co-founded Stanford Biodesign alongside Dr. Paul Yock. They were instrumental in devising “The Biodesign Process” — used […]
CVRx is one of the best performing stocks out of Minnesota
CVRx (Nasdaq:CVRX) reached near the top of a list of Minnesota S&P 500 companies with best-performing stocks. With a 71% return in 2023, CVRx was No. 4 among the Minnesota “Fantastic Four” stocks, according to an analysis in the Star Tribune of Minneapolis. For comparison, the S&P 500 was up 24%. The maker of the […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
FDA clears ZimVie and Brainlab spinal fixation combo
ZimVie announced today that the FDA has cleared the use of its Vital spinal fixation system with Brainlab’s Spine & Trauma Navigation. The news comes just nine months after the companies announced a partnership in which Brainlab will provide spine imaging, planning, navigation, and robotic-assisted systems for use with ZimVie implants. The goal is to enable […]
Microbot Medical is a step closer to an FDA IDE submission
Microbot Medical today announced the successful completion of its pivotal pre-clinical study of its Liberty endovascular robotic surgical system. The study, performed under good laboratory practice (GLP) and essential for the company’s investigational device exemption (IDE) submission, took place under rigorous FDA guidelines. The study involved pigs. In this study, three interventional radiologists performed 96 […]